3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
14
Observational
1
Sponsor
Cancer Type
Plasma cell
3
Classical hematology
2
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Dermatologic
1
Breast
1
Conditions
Neoplasms
1
Muscle Neoplasms
1
Chronic Pain
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
79
Blood Specimen Collection
67
palbociclib
40
Trastuzumab
34
Drug Therapy
30
Letrozole
29
Anastrozole
27
Radiotherapy
26
Immunohistochemistry
26
Mastectomy, Segmental
22
Amplified Fragment Length Polymorphism Analysis
22
Fulvestrant
21
Biopsy
21
exemestane
20
Tamoxifen
20
Interviews as Topic
20
Gene Expression Profiling
20
Magnetic Resonance Spectroscopy
19
ribociclib
18
Specimen Handling
18
Mastectomy
18
Neoadjuvant Therapy
17
Paclitaxel
16
High-Energy Shock Waves
16
Capecitabine
16
trastuzumab deruxtecan
15
Mammography
15
Psychiatric Rehabilitation
14
Polymerase Chain Reaction
13
Observation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Melphalan
×
Breast
×
Clear all
NCT06154590
2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
100 enrolled